OP0253 a Phase Iii Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept or Placebo on Standard of Care in Patients With Active Class Iii or Iv Lupus Nephritis

doi 10.1136/annrheumdis-2018-eular.3451
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Tocilizumab in Patients With Adult-Onset Still’s Disease Refractory to Glucocorticoid Treatment: A Randomised, Double-Blind, Placebo-Controlled Phase III Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2018English

Phase III, Randomised, Double-Blind, Multicentre Study to Evaluate the Efficacy and Safety of Vonoprazan Compared With Lansoprazole in Asian Patients With Erosive Oesophagitis

Gut
Gastroenterology
2019English

Efficacy and Safety of Subcutaneous Tabalumab, a Monoclonal Antibody to B-Cell Activating Factor, in Patients With Systemic Lupus Erythematosus: Results From ILLUMINATE-2, a 52-Week, Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

Journal of Inherited Metabolic Disease
Genetics
2018English

CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2018English

Corrections To: Once-Daily Controlled-Release Pregabalin in the Treatment of Patients With Fibromyalgia: A Phase III, Double-Blind, Randomized Withdrawal, Placebo-Controlled Study

Current Medical Research and Opinion
Medicine
2017English

A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients With Bipolar I Depression

British Journal of Psychiatry
MedicinePsychiatryMental Health
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy